Showing results (21-30 of 418) with videos related to
Sort By:
Pageof 42
Cancer Research|October 2, 2023
RETooling the RET Inhibitor Pralsetinib for ESR1 Fusion-Positive Breast Cancer and BeyondJie Wu, Vivek SubbiahTrends in Cancer|February 21, 2018
Challenging Standard-of-Care Paradigms in the Precision Oncology EraVivek Subbiah, Razelle KurzrockCell Reports. Medicine|September 27, 2023
Clinical development and management of adverse events associated with FGFR inhibitorsVivek Subbiah, Srdan VerstovsekClinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2021
Combination Therapies for Precision Oncology: The Ultimate Whack-A-Mole GameRoman Groisberg, Vivek SubbiahTrends in Cancer|May 11, 2020
Managing Cancer Care during the COVID-19 Pandemic and BeyondOmar Alhalabi, Vivek SubbiahDiscovery Medicine|June 30, 2012
Ewing's sarcoma: overcoming the therapeutic plateauVivek Subbiah, Razelle KurzrockCancer|April 3, 2023
Rare disease research powered by empowered patients: solving the zebra puzzle through social mediaGilberto Morgan, Vivek SubbiahTrends in Cancer|June 20, 2026
Beyond one gene, one target: Next-generation precision oncologyVivek Subbiah, Razelle KurzrockExpert Review of Precision Medicine and Drug Development|December 31, 2019
Immunotherapy and next-generation sequencing guided therapy for precision oncology: What have we learnt and what does the future hold?Roman Groisberg, Vivek SubbiahTrends in Cancer|December 9, 2022
Impact of tissue-agnostic approvals for patients with gastrointestinal malignanciesDeepak Bhamidipati, Vivek SubbiahPageof 42